Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
Adu-Berchie K, Obuseh FO, Mooney DJ. T cell development and function. Rejuvenation Res. 2023.
Hirschhorn D, Budhu S, Kraehenbuehl L, Gigoux M, Schröder D, Chow A, Ricca JM, Gasmi B, De Henau O, Mangarin LMark B, et al. T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants. Cell. 2023;186(7):1432-1447.e17.
Bayegi SNamazi, Hamidieh AAli, Behfar M, Saghazadeh A, Bozorgmehr M, Karamlou Y, Shekarabi M, Tajik N, Delbandi A-A, Zavareh FTofighi, et al. T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia. Transpl Immunol. 2023:101803.
Hang S, Wang N, Sugimura R. T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells. Differentiation. 2023;130:51-57.
Mages S, Moriel N, Avraham-Davidi I, Murray E, Watter J, Chen F, Rozenblatt-Rosen O, Klughammer J, Regev, iv A, Nitzan M. TACCO unifies annotation transfer and decomposition of cell identities for single-cell and spatial omics. Nat Biotechnol. 2023.
Chandhasin C, Dang V, Perabo F, Del Rosario J, Chen YK, Filvaroff E, Stafford JA, Clarke M. TACH101, a first-in-class pan-inhibitor of KDM4 histone demethylase. Anticancer Drugs. 2023.
Dopke KM, Seblani NEl, Mercer K, Naik S, Mainali G, Paul D. Tacrolimus Induced Leukoencephalopathy and Stroke-Like Symptoms: Case Report. Child Neurol Open. 2023;10:2329048X231171011.
Leigh RS, Välimäki MJ, Kaynak BL, Ruskoaho HJ. TAF1 bromodomain inhibition as a candidate epigenetic driver of congenital heart disease. Biochim Biophys Acta Mol Basis Dis. 2023:166689.
You Y, Xu J, Liu Y, Li H, Xie L, Ma C, Sun Y, Tong S, Liang K, Zhou S, et al. Tailored Apoptotic Vesicle Delivery Platform for Inflammatory Regulation and Tissue Repair to Ameliorate Ischemic Stroke. ACS Nano. 2023.
Marouf A, Molinari N, Sibon D, Cottereau AS, Kanoun S, Antoine C, Debureaux PE, Cavalieri D, Fornecker LM, Casasnovas RO, et al. Tandem haematopoietic stem cell transplantation versus single cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA. Br J Haematol. 2023.
Li S, Yang K, Cao W, Guo R, Liu Z, Zhang J, Fan A, Huang Y, Ma C, Li L, et al. Tanshinone IIA enhances the therapeutic efficacy of mesenchymal stem cells derived exosomes in myocardial ischemia/reperfusion injury via up-regulating miR-223-5p. J Control Release. 2023.
Jeon JH, Kaiser EE, Waters ES, Yang X, Lourenco JM, Fagan MM, Scheulin KM, Sneed SE, Shin SK, Kinder HA, et al. Tanshinone IIA-loaded nanoparticles and neural stem cell combination therapy improves gut homeostasis and recovery in a pig ischemic stroke model. Sci Rep. 2023;13(1):2520.
Lu X, Li J, Zhou B, Lu X, Li W, Ouyang J. Taohong Siwu Decoction enhances human bone marrow mesenchymal stem cells proliferation, migration and osteogenic differentiation via VEGF-FAK signaling in vitro. J Ethnopharmacol. 2023:116203.
Lu J, Dai D, Zhang J, Wang R, Miao D, Sun W. Targeted deletion of Rictor in BMSCs reduces the biological activity of K7M2 cells and mitigates OS-induced bone destruction. Stem Cells. 2023.
Kweon J, Jang A-H, Kwon E, Kim U, Shin HRim, See J, Jang G, Lee C, Koo T, Kim S, et al. Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery. Exp Mol Med. 2023.
Sepasi T, Bani F, Rahbarghazi R, Ebrahimi-Kalan A, Sadeghi M-R, Alamolhoda SZahra, Zarebkohan A, Ghadiri T, Gao H. Targeted gene delivery to the brain using CDX-modified chitosan nanoparticles. Bioimpacts. 2023;13(2):133-144.
Biggs D, Chen C-M, Davies B. Targeted Integration of Transgenes at the Mouse Gt(ROSA)26Sor Locus. Methods Mol Biol. 2023;2631:299-323.
Kitata RBirhanu, Hu LY, Lin T-T, Nicora CD, Fillmore TL, Nie S, Hudson RD, Liu T, Leach RJ, Liu AY, et al. Targeted Mass Spectrometry Assays for Specific Quantification of Urinary proPSA Isoforms. J Proteome Res. 2023.
Tynianskaia L, Eşiyok N, Huttner WB, Heide M. Targeted Microinjection and Electroporation of Primate Cerebral Organoids for Genetic Modification. J Vis Exp. 2023;(193).
Li K, Yang D, Liu D. Targeted Nanophotoimmunotherapy Potentiates Cancer Treatment by Enhancing Tumor Immunogenicity and Improving the Immunosuppressive Tumor Microenvironment. Bioconjug Chem. 2023.
Esposito CL, Autiero I, Sandomenico A, Li H, Bassal MA, Ibba ML, Wang D, Rinaldi L, Ummarino S, Gaggi G, et al. Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation. Nat Commun. 2023;14(1):99.
Xie J, Hu Y, Li H, Wang Y, Fan X, Lu W, Liao R, Wang H, Cheng Y, Yang Y, et al. Targeted Therapy for Peri-prosthetic Osteolysis Using Macrophage Membrane-encapsulated Human Urine-derived Stem Cell Extracellular Vesicles. Acta Biomater. 2023.
Zhou K, Gong D, He C, Xiao M, Zhang M, Huang W. Targeted therapy using larotrectinib and venetoclax for the relapsed/refractory T-cell acute lymphoblastic leukemia harboring a cryptic ETV6-NTRK3 fusion. Mol Carcinog. 2023.
D'Addio F, Montefusco L, Lunati MElena, Pastore I, Assi E, Petrazzuolo A, Marin V, Bruckmann C, Fiorina P. Targeting a novel apoptotic pathway in human disease. Bioessays. 2023:e2200231.
Shishido K, Purvis IJ, Velpula KK, Venkataraman S, Vibhakar R, Asuthkar S. Targeting B7‑H3 through EZH2 inhibition in MYC‑positive Group 3 medulloblastoma. Oncol Rep. 2023;49(6).